Sionna Therapeutics Inc.

NASDAQ: SION · Real-Time Price · USD
20.89
-0.02 (-0.10%)
At close: Aug 15, 2025, 3:59 PM
20.82
-0.34%
After-hours: Aug 15, 2025, 04:04 PM EDT

Sionna Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q2 2024 Q1 2024 Q4 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Revenue
n/a n/a n/a n/a n/a n/a
Cost of Revenue
147K n/a n/a 166K n/a n/a
Gross Profit
-147K n/a n/a -166K n/a n/a
Operating Income
-21.91M -19.66M -18.13M -11.29M -13.15M -12.6M
Interest Income
3.67M 3M 2.12M 2.57M 1.13M 553K
Pretax Income
-18.07M -16.48M -15.85M -8.55M -11.85M -11.88M
Net Income
-18.07M -16.48M -15.85M -8.55M -11.85M -11.88M
Selling & General & Admin
6.52M 5.56M 3.88M 2.89M 2.56M 2.71M
Research & Development
15.38M 13.67M 14.25M 8.23M 10.22M 9.89M
Other Expenses
-147K 431K n/a n/a 366K n/a
Operating Expenses
21.76M 19.66M 18.13M 11.13M 13.15M 12.6M
Interest Expense
n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
21.91M 19.66M 18.13M 11.29M 13.15M 12.6M
Income Tax Expense
n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
44.12M 26.6M 42.4M 44.12M 27.8M 17.33M
Shares Outstanding (Diluted)
44.12M 26.6M 42.4M 44.12M 27.8M 17.33M
EPS (Basic)
-0.41 -0.62 -0.37 -0.19 -0.43 -0.69
EPS (Diluted)
-0.41 -0.62 -0.37 -0.19 -0.43 -0.69
EBITDA
-21.91M -19.23M -17.97M -8.39M -12.78M -12.43M
EBIT
-18.07M -19.66M -18.13M -8.55M -13.15M -12.6M
Depreciation & Amortization
147K 159K 167K 166K 166K 161K